Ibritumomab tiuxetan. Definition

Medical Definition: Ibritumomab tiuxetan

Radiolabeled monoclonal antibody used to detect certain types of non-Hodgkin B-cell and is being studied in the detection of other B-cell tumors Monoclonal antibodies are made in the laboratory and can locate substances in the body and bind to, including cancer cells. Ibritumomab binds to the protein CD20, found on B cells It is linked to the compound tiuxetan. This allows certain radioisotopes join him before administering to the patient. A type of monoclonal antibody conjugated with a chelating agent. Also called Zevalin.

* Automatic translation